Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

NCT01558661 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Adenoid Cystic Carcinoma

Interventions

DRUG: AG-013736 (AXITINIB)

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]